Smruthi Organics has received the Brazilian Good Manufacturing Practices (GMP) certificate (Certificado de Boas Praticas de Fabricagdo - CBPF) from the Brazilian Health Regulatory Agency (ANVISA) for the company’s Unit II situated at Chincholi, Solapur, Maharashtra. The certificate is valid up to October 26, 2028.
The certificate has been issued pursuant to Resolution RE No. 4,179 dated October 22, 2026, published in the Official Gazette of Brazil on October 26, 2026, certifying compliance with Good Manufacturing Practices in respect of the active pharmaceutical ingredient Levanlodipine Besylate Hemipentahydrate, manufactured at the company’s Unit.
Earlier, the company had received receipt of the inspection report dated October 8, 2026 issued by the ANVISA for the said unit.
Smruthi Organics is a mid-size, public limited, API manufacturing company from Solapur, India. Its core competency is multi-step organic synthesis and large-scale manufacturing of organic molecules.